1. Home
  2. VCEL vs EVLVW Comparison

VCEL vs EVLVW Comparison

Compare VCEL & EVLVW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCEL
  • EVLVW
  • Stock Information
  • Founded
  • VCEL 1989
  • EVLVW 2013
  • Country
  • VCEL United States
  • EVLVW United States
  • Employees
  • VCEL N/A
  • EVLVW 287
  • Industry
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • EVLVW Computer peripheral equipment
  • Sector
  • VCEL Health Care
  • EVLVW Technology
  • Exchange
  • VCEL Nasdaq
  • EVLVW Nasdaq
  • Market Cap
  • VCEL 2.1B
  • EVLVW N/A
  • IPO Year
  • VCEL 1997
  • EVLVW N/A
  • Fundamental
  • Price
  • VCEL $40.15
  • EVLVW N/A
  • Analyst Decision
  • VCEL Strong Buy
  • EVLVW
  • Analyst Count
  • VCEL 8
  • EVLVW 0
  • Target Price
  • VCEL $62.00
  • EVLVW N/A
  • AVG Volume (30 Days)
  • VCEL 430.8K
  • EVLVW 17.7K
  • Earning Date
  • VCEL 07-31-2025
  • EVLVW 02-28-2025
  • Dividend Yield
  • VCEL N/A
  • EVLVW N/A
  • EPS Growth
  • VCEL 521.85
  • EVLVW N/A
  • EPS
  • VCEL 0.05
  • EVLVW N/A
  • Revenue
  • VCEL $238,541,000.00
  • EVLVW $89,220,000.00
  • Revenue This Year
  • VCEL $23.03
  • EVLVW N/A
  • Revenue Next Year
  • VCEL $24.52
  • EVLVW N/A
  • P/E Ratio
  • VCEL $705.61
  • EVLVW N/A
  • Revenue Growth
  • VCEL 14.80
  • EVLVW 17.67
  • 52 Week Low
  • VCEL $37.39
  • EVLVW $0.28
  • 52 Week High
  • VCEL $63.00
  • EVLVW $0.34
  • Technical
  • Relative Strength Index (RSI)
  • VCEL 44.33
  • EVLVW N/A
  • Support Level
  • VCEL $40.53
  • EVLVW N/A
  • Resistance Level
  • VCEL $43.57
  • EVLVW N/A
  • Average True Range (ATR)
  • VCEL 1.62
  • EVLVW 0.00
  • MACD
  • VCEL -0.16
  • EVLVW 0.00
  • Stochastic Oscillator
  • VCEL 28.65
  • EVLVW 0.00

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About EVLVW Evolv Technologies Holdings Inc.

Evolv Technologies Holdings Inc offers an AI-based touchless security screening. Its touchless security screening systems use artificial intelligence software, cloud services, and sensors to reliably detect dangerous weapons while ignoring harmless items like cell phones, laptops, and keys. It offers products for purchase under a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities. The firm operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.

Share on Social Networks: